Bausch Health Companies Inc. (BHC) stock declined over -0.16%, trading at $6.20 on NYSE, down from the previous close of $6.21. The stock opened at $6.25, fluctuating between $6.17 and $6.45 in the recent session.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Employees | 20270 |
Beta | 0.753 |
Sales or Revenue | $8.76B |
5Y Sales Change% | 0.002% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Bausch Health Companies Inc. (NYSE: BHC) stock price is $6.20 in the last trading session. During the trading session, BHC stock reached the peak price of $6.45 while $6.17 was the lowest point it dropped to. The percentage change in BHC stock occurred in the recent session was -0.16% while the dollar amount for the price change in BHC stock was -$0.01.
The NYSE listed BHC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Bausch Health Companies Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. John S. Barresi
Senior Vice President, Controller & Chief Accounting Officer
Mr. Donald Pearl
Senior Vice President of Ortho Dermatologics
Dr. Robert F. Butz
Vice President of Medical & Scientific Affairs
Mr. Arthur J. Shannon
Senior Vice President and Head of Investor Relations & Global Communications
Ms. Christina S. Cheng CFA
Senior Vice President of Investor Relations
Mr. Thomas J. Appio
Chief Executive Officer & Director
Mr. Thomas G. Vadaketh
Executive Vice President & Chief Financial Officer
Ms. Seana Carson
Executive Vice President & Gen. Counsel
Mr. Mirza Dautbegovic
Senior Vice President & Chief Operating Officer
Ms. Kathleen Fitzpatrick
Senior Vice President & Chief HR Officer
Dr. Tage Ramakrishna M.D.
Chief Medical Officer and Pres of R&D
Mr. Jeff Hartness
Executive Vice President of Market Access, Commercial Operations, Neurology, Generics & Gov. Affairs
Dr. Graham Jackson
Senior Vice President & Chief Quality Officer
Mr. Cees Heiman
Senior Vice President of Europe & Canada
BHC's closing price is 56.57% higher than its 52-week low of $3.96 where as its distance from 52-week high of $11.46 is -45.9%.
Number of BHC employees currently stands at 20,270.
Official Website of BHC is: https://www.bauschhealth.com
BHC could be contacted at phone 151 474 46792 and can also be accessed through its website. BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, Canada.
BHC stock volume for the day was 1.19M shares. The average number of BHC shares traded daily for last 3 months was 3.7M.
The market value of BHC currently stands at $2.28B with its latest stock price at $6.20 and 367.1M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com